[HTML][HTML] Why cell-free DNA can be a “game changer” for lung allograft monitoring for rejection and infection
JP Rosenheck, BC Keller, G Fehringer… - Current Pulmonology …, 2022 - Springer
Abstract Purpose of Review Although there has been improvement in short-term clinical
outcomes for patients following lung transplant (LT), advances have not translated into …
outcomes for patients following lung transplant (LT), advances have not translated into …
[HTML][HTML] Why Cell-Free DNA Can Be a “Game Changer” for Lung Allograft Monitoring for Rejection and Infection
JP Rosenheck, BC Keller, G Fehringer… - Current Pulmonology …, 2022 - ncbi.nlm.nih.gov
There is an amassed breadth of clinical data to support a role for dd-cfDNA in monitoring
rejection and other forms of allograft injury. Rigorously designed, robust clinical trials that …
rejection and other forms of allograft injury. Rigorously designed, robust clinical trials that …
Why Cell-Free DNA Can Be a" Game Changer" for Lung Allograft Monitoring for Rejection and Infection.
JP Rosenheck, BC Keller, G Fehringer… - Current Pulmonology …, 2022 - europepmc.org
There is an amassed breadth of clinical data to support a role for dd-cfDNA in monitoring
rejection and other forms of allograft injury. Rigorously designed, robust clinical trials that …
rejection and other forms of allograft injury. Rigorously designed, robust clinical trials that …
Why Cell-Free DNA Can Be a" Game Changer" for Lung Allograft Monitoring for Rejection and Infection
JP Rosenheck, BC Keller… - Current …, 2022 - pubmed.ncbi.nlm.nih.gov
Purpose of review Although there has been improvement in short-term clinical outcomes for
patients following lung transplant (LT), advances have not translated into longer-term …
patients following lung transplant (LT), advances have not translated into longer-term …